A detailed history of Jump Financial, LLC transactions in Caribou Biosciences, Inc. stock. As of the latest transaction made, Jump Financial, LLC holds 11,954 shares of CRBU stock, worth $19,126. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,954
Holding current value
$19,126
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$4.82 - $8.26 $57,618 - $98,740
11,954 New
11,954 $61,000
Q3 2023

Nov 07, 2023

BUY
$4.08 - $8.14 $376,192 - $750,540
92,204 New
92,204 $440,000
Q1 2023

May 03, 2023

SELL
$4.3 - $7.78 $66,495 - $120,309
-15,464 Reduced 36.25%
27,200 $144,000
Q4 2022

Feb 13, 2023

BUY
$5.57 - $11.01 $237,638 - $469,730
42,664 New
42,664 $267,000
Q2 2022

Aug 09, 2022

SELL
$5.1 - $9.74 $83,640 - $159,736
-16,400 Closed
0 $0
Q1 2022

May 12, 2022

BUY
$8.42 - $15.32 $138,088 - $251,248
16,400 New
16,400 $151,000

Others Institutions Holding CRBU

About Caribou Biosciences, Inc.


  • Ticker CRBU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,840,800
  • Market Cap $97.3M
  • Description
  • Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...
More about CRBU
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.